- Home
- LRMR vs NPCT Comparison
LRMR vs NPCT Comparison
Compare LRMR & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- NPCT
- Stock Information
- Founded
- LRMR N/A
- NPCT 2020
- Country
- LRMR United States
- NPCT United States
- Employees
- LRMR N/A
- NPCT N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- NPCT Investment Managers
- Sector
- LRMR Health Care
- NPCT Finance
- Exchange
- LRMR Nasdaq
- NPCT Nasdaq
- Market Cap
- LRMR 309.8M
- NPCT 314.9M
- IPO Year
- LRMR N/A
- NPCT N/A
- Fundamental
- Price
- LRMR $4.10
- NPCT $10.68
- Analyst Decision
- LRMR Strong Buy
- NPCT
- Analyst Count
- LRMR 7
- NPCT 0
- Target Price
- LRMR $16.71
- NPCT N/A
- AVG Volume (30 Days)
- LRMR 5.0M
- NPCT 107.1K
- Earning Date
- LRMR 11-14-2025
- NPCT 01-01-0001
- Dividend Yield
- LRMR N/A
- NPCT 9.82%
- EPS Growth
- LRMR N/A
- NPCT N/A
- EPS
- LRMR N/A
- NPCT N/A
- Revenue
- LRMR N/A
- NPCT N/A
- Revenue This Year
- LRMR N/A
- NPCT N/A
- Revenue Next Year
- LRMR N/A
- NPCT N/A
- P/E Ratio
- LRMR N/A
- NPCT N/A
- Revenue Growth
- LRMR N/A
- NPCT N/A
- 52 Week Low
- LRMR $1.61
- NPCT $8.58
- 52 Week High
- LRMR $9.50
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- LRMR 47.65
- NPCT 36.16
- Support Level
- LRMR $3.88
- NPCT $10.80
- Resistance Level
- LRMR $4.53
- NPCT $11.00
- Average True Range (ATR)
- LRMR 0.42
- NPCT 0.10
- MACD
- LRMR -0.06
- NPCT -0.02
- Stochastic Oscillator
- LRMR 51.10
- NPCT 5.13
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.